Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Eris Lifesciences enters into term loan agreement with Citi Bank
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
Subscribe To Our Newsletter & Stay Updated
